Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02955940
Title An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL

Facility Status City State Zip Country Details
UCLA Healthcare Hematology-Oncology Santa Monica California 90404 United States Details
University of Louisville Louisville Kentucky 40202 United States Details
New York Oncology Hematology Pc. Clifton Park New York 12065 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
University of Texas M. D. Anderson Cancer Center Houston Texas 77030 United States Details
Renovatio Clinical Consultants Llc The Woodlands Texas 77380 United States Details
Sp Zoz Szpital Uniwersytecki W Krakowie Oddzial Kliniczny Hematologii Krakow 31-501 Poland Details
Samodzielny Publiczny Szpital Kliniczny Lublin 20-081 Poland Details
Instytut Hematologii I Transfuzjologii Warszawa 02-776 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field